Drugs@FDA document

HEPARIN SODIUM Label · NDA 017037 SUPPL-183

Drugs@FDA document · HIKMA PHARMS · Jul 26, 2019

Key facts

Drug name HEPARIN SODIUM
Document type Label
Application NDA017037
Submission SUPPL-183
Company HIKMA PHARMS
Document date Jul 26, 2019
FDA document accessdata.fda.gov

At a glance

  • Manufacturing (CMC)-Formulation Document categories
  • 10–99 Documents for this application
  • None USP chapters cited in this application's documents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA documents

Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date:

Browse all Drugs@FDA documents